These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 26920879)

  • 1. The development of fluconazole resistance in Candida albicans - an example of microevolution of a fungal pathogen.
    Morschhäuser J
    J Microbiol; 2016 Mar; 54(3):192-201. PubMed ID: 26920879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of Fluconazole-Resistant Candida albicans Strains by Drug-Induced Mating Competence and Parasexual Recombination.
    Popp C; Ramírez-Zavala B; Schwanfelder S; Krüger I; Morschhäuser J
    mBio; 2019 Feb; 10(1):. PubMed ID: 30723130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Competitive Fitness of Fluconazole-Resistant Clinical Candida albicans Strains.
    Popp C; Hampe IAI; Hertlein T; Ohlsen K; Rogers PD; Morschhäuser J
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28461316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The stepwise acquisition of fluconazole resistance mutations causes a gradual loss of fitness in Candida albicans.
    Sasse C; Dunkel N; Schäfer T; Schneider S; Dierolf F; Ohlsen K; Morschhäuser J
    Mol Microbiol; 2012 Nov; 86(3):539-56. PubMed ID: 22924823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The genetic basis of fluconazole resistance development in Candida albicans.
    Morschhäuser J
    Biochim Biophys Acta; 2002 Jul; 1587(2-3):240-8. PubMed ID: 12084466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An A643T mutation in the transcription factor Upc2p causes constitutive ERG11 upregulation and increased fluconazole resistance in Candida albicans.
    Heilmann CJ; Schneider S; Barker KS; Rogers PD; Morschhäuser J
    Antimicrob Agents Chemother; 2010 Jan; 54(1):353-9. PubMed ID: 19884367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanism of fluconazole resistance and pathogenicity attributes of Lebanese Candida albicans hospital isolates.
    Fattouh N; Hdayed D; Geukgeuzian G; Tokajian S; Khalaf RA
    Fungal Genet Biol; 2021 Aug; 153():103575. PubMed ID: 34033880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in transcription factor Mrr2p contribute to fluconazole resistance in clinical isolates of Candida albicans.
    Wang Y; Liu JY; Shi C; Li WJ; Zhao Y; Yan L; Xiang MJ
    Int J Antimicrob Agents; 2015 Nov; 46(5):552-9. PubMed ID: 26404130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluconazole induces rapid high-frequency MTL homozygosis with microbiological polymorphism in Candida albicans.
    Ou TY; Chang FM; Cheng WN; Lara A; Chou ML; Lee WF; Lee KC; Lin CT; Lee WS; Yu FL; Su CH
    J Microbiol Immunol Infect; 2017 Dec; 50(6):899-904. PubMed ID: 26928371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An acquired mechanism of antifungal drug resistance simultaneously enables Candida albicans to escape from intrinsic host defenses.
    Hampe IAI; Friedman J; Edgerton M; Morschhäuser J
    PLoS Pathog; 2017 Sep; 13(9):e1006655. PubMed ID: 28953977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A chromosome 4 trisomy contributes to increased fluconazole resistance in a clinical isolate of Candida albicans.
    Anderson MZ; Saha A; Haseeb A; Bennett RJ
    Microbiology (Reading); 2017 Jun; 163(6):856-865. PubMed ID: 28640746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple molecular mechanisms contribute to a stepwise development of fluconazole resistance in clinical Candida albicans strains.
    Franz R; Kelly SL; Lamb DC; Kelly DE; Ruhnke M; Morschhäuser J
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3065-72. PubMed ID: 9835492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted gene disruption in Candida albicans wild-type strains: the role of the MDR1 gene in fluconazole resistance of clinical Candida albicans isolates.
    Wirsching S; Michel S; Morschhäuser J
    Mol Microbiol; 2000 May; 36(4):856-65. PubMed ID: 10844673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the multi-drug resistance regulator MRR1, followed by loss of heterozygosity, are the main cause of MDR1 overexpression in fluconazole-resistant Candida albicans strains.
    Dunkel N; Blass J; Rogers PD; Morschhäuser J
    Mol Microbiol; 2008 Aug; 69(4):827-40. PubMed ID: 18577180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gain-of-function mutations in the transcription factor MRR1 are responsible for overexpression of the MDR1 efflux pump in fluconazole-resistant Candida dubliniensis strains.
    Schubert S; Rogers PD; Morschhäuser J
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4274-80. PubMed ID: 18809934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deciphering azole resistance mechanisms with a focus on transcription factor-encoding genes TAC1, MRR1 and UPC2 in a set of fluconazole-resistant clinical isolates of Candida albicans.
    Morio F; Pagniez F; Besse M; Gay-andrieu F; Miegeville M; Le Pape P
    Int J Antimicrob Agents; 2013 Nov; 42(5):410-5. PubMed ID: 24051054
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Gerstein AC; Berman J
    mSphere; 2020 Jun; 5(3):. PubMed ID: 32581072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evolution of drug resistance in clinical isolates of Candida albicans.
    Ford CB; Funt JM; Abbey D; Issi L; Guiducci C; Martinez DA; Delorey T; Li BY; White TC; Cuomo C; Rao RP; Berman J; Thompson DA; Regev A
    Elife; 2015 Feb; 4():e00662. PubMed ID: 25646566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The transcription factor Mrr1p controls expression of the MDR1 efflux pump and mediates multidrug resistance in Candida albicans.
    Morschhäuser J; Barker KS; Liu TT; BlaB-Warmuth J; Homayouni R; Rogers PD
    PLoS Pathog; 2007 Nov; 3(11):e164. PubMed ID: 17983269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
    Jensen RH
    Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.